Clinical Research Physician – Incretins at Eli Lilly and Company

Indianapolis, Indiana, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, HealthcareIndustries

Requirements

Scientific and medical training, clinical expertise, and relevant clinical experience
Ability to develop or contribute to global and/or regional clinical/medical plans in the therapeutic area of responsibility (Diabetes and Obesity, Incretins)
Experience in the development, conduct, and reporting of clinical trials, including implementation of global clinical trials in local affiliates/countries
Knowledge of adverse event reporting as mandated by corporate patient safety
Proficiency in review processes for protocols, study reports, publications, data dissemination, new/updated labels, PRA documents/tools, grant submissions, and contracts
Capability to engage with regulatory and governmental agencies
Skills in outreach medical activities with external clinical customer community, including thought leaders
Awareness and ensuring compliance with local/international regulations, laws, guidance (e.g., FDA, ICH, CPMP), Good Clinical Practices (GCPs), company standards, Lilly policies/procedures, global quality standards, and Principles of Medical Research
Ability to serve as a scientific resource for study teams, departments, and others

Responsibilities

Provide expert medical support to all aspects of local/global business to enhance customers' (patients, HCPs, payers) experience
Participate in development of the "patient journey" and strategic plan for compounds (marketed product support)
Provide medical support for regulatory affairs, including New and Supplemental New Drug Submissions and presenting at meetings with government regulatory agencies
Offer medical guidance on Pricing, Reimbursement, and Access (PRA) plans and interact with government PRA agencies as needed
Lead scientific data dissemination, including presenting at conferences/advisory boards and overseeing scientific content of educational programs
Work closely with global Development teams, Therapeutic Area Program Phase, Early Phase/Clinical Pharmacology, and Translational Medicine teams in new product development across drug development and clinical trial phases
Support demand realization through various medical activities
Ensure all medical team activities (and direct reports, if applicable) align with medical vision and comply with regulations

Skills

Clinical Trials

Medical Affairs

Diabetes

Obesity

Incretins

Adverse Event Reporting

Protocol Review

Strategic Planning

Commercialization

Reimbursement

Product Launch

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free